Basic Information
Basic information for SNHG14-292-21aa
Peptide Name SNHG14-292-21aa
Genome Position chr15:25419774-25419836[+]
Species Human
Peptide Sequence MYTIPKFLHYTLRGIIFLKVD
Peptide Length 21
Unique No (SNHG14-203-21aa,SNHG14-226-21aa,SNHG14-228-21aa-2,SNHG14-229-21aa,SNHG14-244-21aa-2,SNHG14-245-21aa,SNHG14-266-21aa,SNHG14-284-21aa,SNHG14-285-21aa,SNHG14-294-21aa,SNHG14-295-21aa-2,SNHG14-306-21aa,SNHG14-320-21aa,SNHG14-328-21aa,SNHG14-329-21aa-2,SNHG14-331-21aa-2)
Grand Average of Hydropathicity 0.5524
Relative Molecular Mass 2929.5
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000224078;SNHG14
Transcript ID/Name ENST00000664763;SNHG14-292
Transcript Length 4267
Coding Ability 0.442
DNA Sequence Corresponding to Peptide ATGTATACTATTCCAAAATTCTTACATTATACATTAAGAGGAATAATATTTTTGAAGGTAGAT
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :